A recombinant DNA strategy has been used systematically to survey the Mycobacterium tuberculosis genome for sequences that encode specific antigens detected by monoclonal antibodies. M. tuberculosis genomic DNA fragments with randomly generated endpoints were used to construct a large Xgtll recombinant DNA expression library. Sufficient numbers of recombinants were produced to contain inserts whose endpoints occur at nearly every base pair in the pathogen genome. Protein antigens specified by linear segments of pathogen DNA and produced by the recombinant phage of Escherichia coli were screened with monoclonal antibody probes. This approach was coupled with an improved detection method for gene isolation using antibodies to clonally isolate DNA sequences that specify polypeptide components of M. tuberculosis. The methodology described here, which is applicable to other pathogens, offers possibilities for the development of more sensitive and specific immunodiagnostic and seroepidemiological tests for tuberculosis and, ultimately, for the development of more effective vaccines.
Mycobacteria were the first bacterial pathogens of man to be described (1, 2) and continue to produce devastating illness, particularly in developing countries (3) (4) (5) (6) . Tuberculosis is caused by respiratory infection with Mycobacterium tuberculosis and currently afflicts 30 million people in the world, exacting an annual mortality of 3 million. While infection may be asymptomatic in some individuals, in others it produces damaging pulmonary lesions leading to severe debilitation. If the infection is not restricted by immune responses, it can disseminate to the major organs of the body, most frequently in a fatal form. Mycobacterium leprae is the etiologic agent of leprosy and remains the only major bacterial pathogen of man which has not yet been cultivated. A variety of mycobacterial species once thought to be nonpathogenic have been increasingly found to produce atypical mycobacteriosis in immunocompromised hosts.
To combat mycobacterial diseases, crude bacterial preparations have been used for immunodiagnostic and immunoprophylactic purposes. The tuberculin skin test developed by Koch (7) was the first immunodiagnostic test used in man. Tuberculin, an M. tuberculosis filtrate of complex but poorly defined composition, is used as a skin test antigen to detect prior exposure to the pathogen (8) . Unfortunately, tuberculin's usefulness is limited both by its lack of specificity and by its inability to distinguish between active disease, prior sensitization by contact with M. tuberculosis, or crosssensitization to other mycobacteria. Bacillus Calmette-Guerin (BCG) (9) , an avirulent strain of Mycobacterium bovis, is used widely as a live vaccine to protect against tuberculosis in man. While it appears to have been effective in reducing the incidence of tuberculosis in Western Europe (10), it has recently been found ineffective in a major trial in India (11) .
A means to survey all of the protein antigens of any pathogen could facilitate the identification of specific serodiagnostic tools and would be a useful prerequisite to selecting a polypeptide vaccine candidate for further study. Recombi (12, 13) . The use of an efficient screening method permits a survey of the antigens expressed by approximately 106 independent recombinant phage in a single experiment. Individual recombinant clones that produce the antigen of interest can be isolated and subjected to further study.
A number of features of the strategy described here are important for a thorough survey of the antigens encoded in a foreign genome. In particular, steps must be taken to maximize the probability that all antigen-coding sequences are expressed. The bacteriophage vector Xgtll expresses the insert DNA as a fusion protein connected to the E. coli ,B-galactosidase polypeptide. The fusion protein approach assures that the foreign sequence will be efficiently transcribed and translated in E. coli. To ensure that all of the coding sequences in the genome of interest are expressed requires the construction of a recombinant DNA library whose foreign DNA inserts are present in all orientations and translational frames. Thus, it is essential to generate a large number of insert DNA fragments whose endpoints occur at random throughout the foreign genome. The ideal recombinant DNA library for this purpose would contain a sufficiently large number of individual recombinants to accommodate DNA inserts with endpoints that occur at each base pair throughout the foreign genome.
To ensure that all expressed antigens can accumulate to detectable levels in E. coli, particular attention has been paid to the highly unstable nature of most foreign proteins in the bacterium. The fusion protein approach helps; fusion proteins are often more resistant to proteolytic degradation than is the foreign polypeptide alone (14, 15) . Moreover, the fusion point in Xgtll appears to increase the lifetime of the fusion protein, especially in Ion protease-deficient strains of the bacterium (12) .
These features of the Xgtll expression method have been coupled with an improved antigen screening protocol, supeAbbreviations: kb, kilobase pair(s); pfu, plaque forming unit(s).
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Biochemistry: Young et alP rior in sensitivity and efficiency to that previously described (13) , to isolate DNA sequences that specify antigens found in Mycobacterium tuberculosis.
MATERIALS AND METHODS
Phage and Bacterial Strains. Xgtll and the E. coli strains Y1088, Y1089, and Y1090 have been described (12, 13) .
Growth of M. tuberculosis and DNA Isolation. M. tuberculosis "Erdman," TMC 107, lot 9A-2, was obtained in frozen form (2.5 x 109 colony forming units/ml) from F. M. Collins (Trudeau Institute, Inc., Saranac Lake, NY). Bacteria were grown to late exponential phase in Proskauer and Beck medium as modified from the original description by Youmans (16) . The medium was made by adding 5 g of asparagine, 5 g of KH2PO4, and 0.5 g of K2SO4 to 1 liter of glycerol solution (20 ml of glycerol in 980 ml of water), adjusting the pH to 7.0, and then adding 1.5 g of magnesium citrate; the medium was autoclaved for 20 min. Bacteria grew as a pellicle at 37°C in roller bottles at 1 rpm. After about 10 days, bacteria were harvested by centrifugation at 1500 X g for 20 min. To 200 Al of pelleted bacterial cells, 1 ml of acid-washed glass beads (0.45-to 0.50-mm diameter) were added, followed by 3 ml of homogenization buffer (0.1 M NaCl/0.03 M Tris, pH 7.5/0.006 M EDTA). This mixture was homogenized for 2 min in a Braun rotary homogenizer at high speed at 0-5°C. An equal volume of a 1:1 (vol/vol) mixture of chloroform and phenol was then added, and the homogenate was extracted with gentle agitation for 10 min. Debris was pelleted by centrifugation at 1500 x g for 30 min. Chloroform/phenol extraction of the aqueous phase was repeated. The aqueous phase was then extracted once with an equal volume of a 24:1 (vol/vol) mixture of chloroform and isoamyl alcohol with gentle agitation for 10 min, followed by centrifugation at 1500 x g for 30 min. Sodium acetate was added to 0.3 M in the aqueous phase, and DNA was precipitated with 2.5 vol of chilled EtOH. DNA was pelleted by centrifugation at 10,000 x g for 20 min, lyophilized, and resuspended in 1 ml of 0.1 M sodium acetate (pH 5.5). DNase-free RNase was added to 0.1 mg/ml, and the mixture was incubated at 37°C for 1 hr. Finally, the DNA was extracted with chloroform/ phenol twice, precipitated with EtOH, and collected by cenCells trifugation. The DNA pellet was resuspended in 0.02 M Tris, pH 7.5/0.1 M NaCl/0.0001 M EDTA at a concentration of 0.35 mg/ml (A260/A280 ratio was 1.80 Proc. NatL Acad Sci. USA 82 (1985) Proc. NatL. Acad Sci. USA 82 (1985) 2585 0.4 ml of 1 M NaCl containing 0.05 M arginine (free base). The filter was incubated at 70'C for 2 hr to elute the DNA. The NA45 was removed, EtOH was added to fill the Eppendorf tube, and DNA was precipitated at -200C for 2 hr. The DNA was resuspended in TE buffer and ligated with 1 pg of EcoRI-digested Xgtll DNA that had been dephosphorylated to improve the frequency of recombinant phage (17) . The library was packaged and amplified on E. coli Y1088 at 420C as described (13, 18) .
Screening Libraries in Xgtll with Antibody Probes. Y1090 was grown to saturation in LB soft agar (pH 7.5) (18) chloro-1-napthol in methanol (3 mg/ml) with 10 ml of Tris/ NaCl. Just prior to adding the filter, 5 ,ul of 30% hydrogen peroxide was added. After the color developed, filters were washed with two changes of distilled water and allowed to dry.
RESULTS AN) DISCUSSION
A Xgtll recombinant DNA expression library of M. tuberculosis DNA was constructed by using the strategy depicted in Fig. 1 . Genomic DNA was isolated from M. tuberculosis and mechanically sheared to produce fragments of 2-8 kb. EcoRI linkers were added to the ends of the DNA fragments to allow insertion at the unique EcoRI site of the Xgtll phage. The ligated recombinant DNA was packaged into phage heads, and this material was used to infect E. coli cells to produce a library. The aim of this approach was to generate DNA fragments with random endpoints throughout the foreign genome and then to produce recombinant phage in sufficient numbers that insert endpoints would occur be- phage were arrayed on plates and probed with the monoclonal antibodies TB78, TB68, and TB23 as well as the antibody pool used in the initial isolation of these phage.
x 106 individual recombinant phage. This library was amplified in E. coli Y1088 (13) by producing a plate stock (16) whose titer was 10"l pfu/ml. The amplified library consisted of 40% recombinants whose foreign DNA insert sizes averaged 4 kb as determined by DNA restriction endonuclease analysis of 40 independent phage clones.
Several features of the original Xgtll antibody screening protocol (13) were modified to obtain improved sensitivity and permit a more thorough and efficient screen of the Xgtll library. In particular, biotinylated secondary antibody was used to detect bound primary antibody, which in turn was bound by biotin-avidin-coupled horseradish peroxidase.
This approach had several advantages over the use of 1251_ labeled protein A: the choice of a primary antibody did not depend on its ability to bind protein A, good signal-to-noise ratios were obtained with greater primary antibody dilution, no false-positive signals were observed, and the precise signal-producing plaque could be located by comparing the faint background pattern produced by neighboring plaques on the nitrocellulose filter with the pattern of plaques on the agar plate (Fig. 2) .
Four different monoclonal antibodies were used to screen the Xgtll M. tuberculosis library. These monoclonal antibodies, TB78, TB71, TB68, and TB23, are directed against abundant M. tuberculosis proteins of 33, 41, 16, and 18 kDa, respectively (19) . The antibodies were produced by immunization of mice with pressure-disrupted M. tuberculosis bacilli or with sonicated cell-free extracts followed by spleen cellplasmocytoma fusion to generate hybridomas; details of their isolation and characterization have been reported (19, 20) . A pool of the four antibodies was used to probe 40 150-mm filters, each containing antigen from 5 x 104 individual plaques (of which 40% are produced by recombinant phage), and 73 signals were observed. Fig. 2 Xgtll recombinant DNA expression libraries constructed with cDNA (21) and with DNase-digested genomic DNA (22) have been used to isolate genes by using antibodies directed against other human pathogens. These libraries may not contain insert DNA that is representative of all of the coding sequences of interest in a pathogen genome: cDNA is biased toward the more abundant mRNAs, and DNase can act on genomic DNA in a nonrandom fashion (22) . The approach described here attempts to minimize these biases. Part of the power of this approach lies in the potential to detect any epitope encoded in an organism's genome, even if it is not always expressed.
The ability to isolate segments of DNA that encode specific pathogen epitopes should facilitate the development of reagents useful for diagnosis and prophylaxis of human disease. For example, it is conceivable that some DNA fragments will be a source of specific serodiagnostic and skintest antigens, important for monitoring disease transmission and the effectiveness of vaccination or therapy. Finally, it may be possible to introduce genes that specify polypeptides necessary for immunological protection into cultivatable mycobacteria to produce more specific and effective vaccines.
